Price Alert

Edwards Lifesciences Corp... (EW)

NYSE: EW · Real-Time Price · USD

77.92

-0.26 (-0.33%)

At close: Aug 15, 2025, 12:22 PM

Edwards Lifesciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	1.53B	1.41B	1.39B	1.35B	1.39B	1.33B	1.27B	1.24B	1.3B	1.46B	1.35B	1.32B	1.37B	1.34B	1.33B	1.31B	1.38B	1.22B
Cost of Revenue	342.6M	301.6M	292.2M	262.9M	297.8M	289.3M	251M	272.2M	270.8M	359.3M	295.6M	280.9M	285.7M	306.6M	311.1M	300.9M	326M	287.9M
Gross Profit	1.19B	1.11B	1.09B	1.09B	1.09B	1.04B	1.02B	971.2M	1.02B	1.1B	1.05B	1.04B	1.09B	1.03B	1.02B	1.01B	1.05B	928.7M
Operating Income	430.9M	394.8M	312.6M	350.6M	364.7M	355.5M	356.7M	346.5M	370.6M	402.8M	409.5M	427.2M	428.4M	435.7M	361.8M	407.2M	450.6M	390.8M
Interest Income	37.4M	19.5M	44.2M	23.5M	16.5M	19M	16.8M	16.3M	12.9M	6.9M	6.3M	5.1M	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	400.2M	433.9M	390.1M	402.8M	386.6M	371.2M	367.2M	387.6M	275.1M	398.6M	459.3M	407.3M	464.7M	436.1M	376.3M	390.9M	545.5M	389.3M
Net Income	333.2M	358M	385.6M	3.07B	366.3M	351.9M	369.9M	384.9M	307.1M	340.5M	398.4M	343.5M	406.4M	373.6M	335.3M	340.1M	489.5M	338.2M
Selling & General & Admin	502M	465.7M	491.9M	421.4M	450.8M	428.4M	416.6M	381.9M	410.4M	436.3M	411M	377.3M	409M	370.3M	424M	364.1M	374.1M	330.9M
Research & Development	276.2M	254.6M	271.1M	253.4M	272.6M	256.7M	242.1M	242.8M	243.7M	261.2M	232.2M	233.6M	250.8M	228.6M	232.8M	238M	225.3M	207M
Other Expenses	-19.5M	-4M	18M	66.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	758.7M	716.3M	781M	740.9M	723.4M	685.1M	658.7M	624.7M	654.1M	697.5M	643.2M	610.9M	659.8M	598.9M	656.8M	602.1M	599.4M	537.9M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.1M	1M	1.2M	2.4M	2.5M	1.3M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.1B	1.01B	1.07B	1B	1.02B	974.4M	909.7M	896.9M	924.9M	1.06B	938.8M	891.8M	945.5M	905.5M	967.9M	903M	925.4M	825.8M
Income Tax Expense	64.3M	70.3M	45.1M	40.7M	20.2M	46.3M	34.1M	52.7M	20.9M	58.1M	60.9M	63.8M	58.3M	62.5M	41M	50.8M	56M	51.1M
Shares Outstanding (Basic)	587M	586.9M	589.8M	597.2M	602.1M	601.6M	605.2M	607M	606.9M	607.5M	612.9M	619.8M	620.9M	622.1M	624.1M	623.6M	622.3M	623.2M
Shares Outstanding (Diluted)	587.9M	587.8M	590.5M	598.1M	604.3M	604.1M	606.9M	609.5M	610.3M	610.9M	616.2M	624.5M	626.7M	629.4M	632M	631.7M	629.9M	631.3M
EPS (Basic)	0.57	0.61	0.65	5.14	0.61	0.58	0.61	0.63	0.51	0.56	0.65	0.55	0.65	0.60	0.54	0.55	0.79	0.54
EPS (Diluted)	0.57	0.61	0.65	5.13	0.61	0.58	0.61	0.63	0.50	0.56	0.65	0.55	0.65	0.59	0.53	0.54	0.78	0.54
EBITDA	400.2M	470.5M	432.7M	437.3M	426.2M	409.7M	403.9M	424.5M	311.2M	440.6M	501.3M	449.4M	506.7M	478.9M	417.6M	434M	590.8M	430.3M
EBIT	400.2M	433.9M	390.1M	402.8M	386.6M	371.2M	367.2M	387.6M	275.1M	398.6M	459.3M	407.3M	465.8M	437.1M	377.5M	393.3M	548M	390.6M
Depreciation & Amortization	n/a	36.6M	42.6M	34.5M	39.6M	38.5M	36.7M	36.9M	36.1M	42M	42M	42.1M	40.9M	41.8M	40.1M	40.7M	42.8M	39.7M